Evidence map›Paper›PMID 35459913›Full record

ArticleSignal transduction and targeted therapy2022

Novel potential metabolic biomarker panel for early detection of severe COVID-19 using full-spectrum metabolome and whole-transcriptome analyses.

Zhi-Bin Li, Jun Liu, Shan-Qiang Zhang, Yi Yu, Hong-Feng Liang, Qi-Qi Lu, Jing Chen, Yu-Shuai Han, Fan Zhang, Ji-Cheng Li

Abstract readLetter
In one paragraph

Article in Signal transduction and targeted therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhi-Bin Li *The Central Laboratory, Yangjiang People's Hospital, 529500, Yangjiang, China.
Jun Liu *Medical Research Center, Yue Bei People's Hospital, Shantou University Medical College, 512025, Shaoguan, China.
Shan-Qiang Zhang *Medical Research Center, Yue Bei People's Hospital, Shantou University Medical College, 512025, Shaoguan, China.
Yi YuThe Central Laboratory, Yangjiang People's Hospital, 529500, Yangjiang, China.
Hong-Feng LiangThe Central Laboratory, Yangjiang People's Hospital, 529500, Yangjiang, China.
Qi-Qi LuMedical Research Center, Yue Bei People's Hospital, Shantou University Medical College, 512025, Shaoguan, China.
Jing ChenThe Central Laboratory, Yangjiang People's Hospital, 529500, Yangjiang, China.
Yu-Shuai HanThe Central Laboratory, Yangjiang People's Hospital, 529500, Yangjiang, China.
Fan ZhangMedical Research Center, Yue Bei People's Hospital, Shantou University Medical College, 512025, Shaoguan, China.
Ji-Cheng LiThe Central Laboratory, Yangjiang People's Hospital, 529500, Yangjiang, China. lijichen@zju.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19BiomarkersGene Expression ProfilingHumansMetabolomeBiomarkers

Identifiers

PMID35459913
PMCPMC9026054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.